Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: Role of the farnesoid X receptor
- 1 June 2005
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 69 (12), 1755-1763
- https://doi.org/10.1016/j.bcp.2005.03.019
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Role of Mitochondrial Dysfunction in Combined Bile Acid-Induced Cytotoxicity: The Switch Between Apoptosis and NecrosisToxicological Sciences, 2004
- Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administrationGut, 2003
- Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisitedHepatology, 2002
- Interactions of combined bile acids on hepatocyte viability: cytoprotection or synergismToxicology Letters, 2001
- Ursodeoxycholic acid ‘mechanisms of action and clinical use in hepatobiliary disorders’Journal of Hepatology, 2001
- Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseasesAlimentary Pharmacology & Therapeutics, 1999
- Identification of a Nuclear Receptor for Bile AcidsScience, 1999
- Bile Acids: Natural Ligands for an Orphan Nuclear ReceptorScience, 1999
- Ursodeoxycholic Acid May Inhibit Deoxycholic Acid-Induced Apoptosis by Modulating Mitochondrial Transmembrane Potential and Reactive Oxygen Species ProductionMolecular Medicine, 1998
- Pharmacology of Ursodeoxycholic Acid, an Enterohepatic DrugScandinavian Journal of Gastroenterology, 1994